2004
DOI: 10.1097/01.tp.0000140770.81537.64
|View full text |Cite
|
Sign up to set email alerts
|

Acute Vascular Rejection and Accommodation: Divergent Outcomes of the Humoral Response to Organ Transplantation

Abstract: These findings suggest that control of complement may underlie accommodation, at least in part, and raise the possibility that this control and possibly other protective mechanisms could be exerted by heparan sulfate.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
56
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 80 publications
(59 citation statements)
references
References 45 publications
3
56
0
Order By: Relevance
“…Furthermore, our findings that phosphorylation of Akt is most prominent when EC are treated with low concentrations of anti-class I Ab are in accordance with previous studies showing exposure of EC to subsaturating concentrations of anti-HLA Ab increases the expression of Bcl-2 and Bcl-x L and renders the EC refractory to cell lysis (10,16,17). Therefore, similar to anti-ABO Ab, anti-HLA Ab can induce the expression of antiapoptotic proteins that may promote a state of accommodation in the allograft (35). Our studies confirm and extend these findings by identifying FAK as a key upstream tyrosine kinase controlling anti-HLA Ab-mediated prosurvival signaling.…”
Section: Discussionsupporting
confidence: 73%
“…Furthermore, our findings that phosphorylation of Akt is most prominent when EC are treated with low concentrations of anti-class I Ab are in accordance with previous studies showing exposure of EC to subsaturating concentrations of anti-HLA Ab increases the expression of Bcl-2 and Bcl-x L and renders the EC refractory to cell lysis (10,16,17). Therefore, similar to anti-ABO Ab, anti-HLA Ab can induce the expression of antiapoptotic proteins that may promote a state of accommodation in the allograft (35). Our studies confirm and extend these findings by identifying FAK as a key upstream tyrosine kinase controlling anti-HLA Ab-mediated prosurvival signaling.…”
Section: Discussionsupporting
confidence: 73%
“…Especially as BGA persist in all of our recipients of ABO-incompatible renal allografts, such longer term studies are needed to determine whether diffuse C4d staining without evidence of rejection truly reflects a state of graft accommodation, in which the organ continues to function well despite the presence of antibodies directed against it. 23 The finding of diffuse PTC C4d staining without histologic evidence of rejection on one or more early protocol biopsies did not preclude later development of AMR, although the latter was rare in this study. Only one of 21 group A patients compared with three of 12 group B patients developed AMR, although this difference did not reach statistical significance and no grafts in either group were lost to AMR.…”
Section: Discussionmentioning
confidence: 44%
“…Inhibition of the complement cascade distal to C4 cleavage by factors such as decay-accelerating factor, CD59, and heparan sulfate may play a vital role in determining whether grafts exposed to such antibody develop AMR or show accommodation. 23,33,34 Indeed, recent studies in a heart xenograft model similar to that noted already demonstrated elevated expression of decay-accelerating factor, CD59, and Crry (a rodent complement regulatory protein) on capillary endothelial cells of accommodating grafts. 34 The regulation of expression of these factors in human allografts and how this is affected by binding of antibodies against blood group and HLA antigens expressed on the graft remain important areas for future study.…”
Section: Discussionmentioning
confidence: 99%
“…In any case, C4d deposition in ABO-incompatible grafts can be seen routinely without features of AHR and therefore is of limited value. Perhaps deposition of later complement components (C5b or MAC) or absence of heparan sulfate and syndecan-4-phosphate will show more correlation with injury, as has been reported in xenografts (53). C4d deposition also occurs in 2 to 26% of histologically normal ABO-compatible grafts, the higher frequency found in HLA-presensitized patients (8,54) ( Figure 5).…”
Section: Accommodationmentioning
confidence: 72%